Acute side effects of radiation therapy : a guide to management /

Saved in:
Bibliographic Details
Author / Creator:Sourati, Ainaz, author.
Imprint:Cham : Springer, 2017.
Description:1 online resource
Language:English
Subject:
Format: E-Resource Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/11308004
Hidden Bibliographic Details
Other authors / contributors:Ameri, Ahmad, author.
Malekzadeh, Mona, author.
ISBN:9783319559506
3319559508
9783319559490
3319559494
Digital file characteristics:text file PDF
Notes:Includes bibliographical references at the end of each chapters and index.
Online resource; title from PDF title page (EBSCO, viewed June 21, 2017).
Summary:This book provides clear guidance on how to manage a wide range of side effects frequently encountered when treating patients with radiation therapy. For each potential side effect, incidence, mechanism, symptoms, and grading are carefully described. All aspects of management are addressed, drawing on the latest available evidence and highlighting key details of importance in clinical routine. The introduction of new radiation therapy techniques such as 3D conformal radiation therapy, intensity-modulated radiation therapy, and image-guided radiation therapy has reduced normal tissue doses and, accordingly, treatment complications. Nevertheless, a significant percentage of patients still experience acute side effects, in part because the threshold doses for these toxicities are typically lower than those for late effects. Acute toxicities may lead to interruption of treatment and be associated with an increase in late damage. A swift and effective response is therefore essential. This book will enable the reader to provide effective care for each side effect, thereby improving patient compliance with treatment and treatment outcomes.
Other form:Print version: Sourati, Ainaz. Acute side effects of radiation therapy. Cham : Springer, 2017 9783319559490 3319559494
Standard no.:10.1007/978-3-319-55950-6
Table of Contents:
  • Foreword; Introduction; 1: Radiation Dermatitis; 1.1 Mechanism; 1.2 Timing; 1.3 Sign and Symptoms; 1.4 Scoring; 1.5 Risk Factors; 1.5.1 Treatment-Related Factors Including; 1.5.2 Patient-Related Factors Include; 1.6 Diagnosis; 1.7 Prevention; 1.7.1 General Measures; 1.7.2 Intensity-Modulated Radiation Therapy (IMRT); 1.7.3 Low-Level Laser Therapy; 1.7.4 Amifostine; 1.7.5 Ascorbic Acid; 1.7.6 Oral Zinc; 1.7.7 Silver Leaf Dressing; 1.7.8 MAS065D; 1.7.9 Soft Dressing or Barrier Film; 1.7.10 Hyaluronic Acid; 1.7.11 Trolamine; 1.7.12 Topical Sucralfate; 1.7.13 Theta Cream.
  • 1.7.14 Dexpanthenol (Provitamin B5)1.7.15 Calendula; 1.7.16 Pentoxifylline; 1.7.17 Aloe Vera; 1.7.18 Deodorant; 1.7.19 Laughter Therapy; 1.8 Management; 1.8.1 Grade 1 Dermatitis; 1.8.2 Grade 2-3 Dermatitis; 1.8.3 Grade 4 Dermatitis; References; 2: Hair Loss; 2.1 Mechanism; 2.2 Timing; 2.2.1 Risk Factors; 2.2.2 Symptoms; 2.3 Scoring; 2.4 Prevention; 2.5 Management; References; 3: Radiation Brain Injury; 3.1 Mechanism; 3.2 Timing; 3.3 Risk Factors; 3.3.1 Treatment-Related Factors; 3.3.2 Patient-Related Factor; 3.4 Symptoms; 3.5 Diagnosis; 3.6 Scoring.
  • 3.7 Prevention and Management3.7.1 Dexamethasone Prescription; References; 4: Radiation Orbital Toxicity; 4.1 Blepharitis and Eyelid Dermatitis; 4.2 Eyelash Loss; 4.3 Conjunctivitis; 4.4 Xerophthalmia; 4.5 Corneal Toxicity; 4.5.1 Treatment; 4.5.1.1 Topical Lubricants (e.g., Ophthalmic Ointment); 4.5.1.2 Analgesics; 4.5.1.3 Ophthalmologist Consult; 4.6 Iris Toxicity; References; 5: Ear Toxicity; 5.1 Mechanism; 5.2 Timing; 5.3 Risk Factors; 5.4 Symptoms and Diagnosis; 5.5 Scoring; 5.6 Management; References; 6: Oral Mucositis; 6.1 Mechanism; 6.2 Timing; 6.3 Risk Factors.
  • 6.3.1 Tumor Site6.3.2 Concomitant Systemic Therapy; 6.3.3 Radiation Dose; 6.3.4 Radiation Fractionation Schedule; 6.3.5 Patient-Related Factors; 6.4 Symptoms; 6.5 Scoring; 6.6 Prevention; 6.6.1 Prophylactic Interventions; 6.6.2 Prophylactic Intervention Under Evaluation; 6.7 Management; 6.7.1 Patient Assessment; 6.7.2 Mouth Care; 6.7.3 Management of Oral Pain; 6.7.3.1 Benzydamine Mouth Wash; 6.7.3.2 Doxepin; 6.7.3.3 Magic Mouthwash; 6.7.3.4 Gelclair; 6.7.3.5 CAM2028; 6.7.3.6 MF 5232; 6.7.3.7 Acetylcysteine; 6.7.3.8 Opiates; 6.7.3.9 Corticosteroids; 6.7.3.10 Gabapentin.
  • 6.7.3.11 Other Analgesic Agents6.7.3.12 Sucralfate; 6.7.3.13 Phenytoin Mouthwash; 6.7.3.14 Low-Level Laser Therapy; 6.7.4 Antifungals; 6.7.5 Antivirals; 6.7.6 Feeding Tube/Nutritional Support; References; 7: Xerostomia; 7.1 Mechanism; 7.2 Timing; 7.3 Risk Factors; 7.4 Symptoms; 7.5 Diagnosis; 7.6 Scoring; 7.7 Prevention; 7.7.1 Amifostin; 7.7.1.1 Prescription; 7.7.1.2 Contraindications; 7.7.1.3 Advers effects; 7.7.2 IMRT; 7.7.3 Submandibular gland transfer; 7.7.4 Pilocarpine; 7.7.4.1 Prescription; 7.7.4.2 Contraindications; 7.7.5 Acupuncture; 7.8 Management.